Lloyd Mulenga

Dados Biográficos

ID7013383
NOMELloyd Mulenga
PRENOMESLloyd
SOBRENOMEMulenga
ASSINATURAMULENGA L
AFILIAÇÕESMinistry of Health
ORCID0000-0002-1044-4209
VERIFICADOSim
TOTAL DE OBRAS12
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR12
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2008
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H0

  • Patterns of engagement in care during clients’ first 12 months after HIV treatment initiation in Zambia

    Open AccessMariet Benade, Mhairi Maskew et al.ARTICLEBMJ Global Health2025

    BACKGROUND: The first year after HIV treatment initiation or re-initiation is the period of highest risk of a treatment interruption or disengagement, yet little is known about the timing, patterns and effects of interruptions in the early treatment period. METHODS: Using routinely collected electronic medical record data from 543 Zambian facilities from 2018 to 2023, we described patterns of engagement during the first year of HIV treatment. We …

  • Implementing Sars-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022

    Open AccessTannia Tembo, Elizabeth Heilmann et al.ARTICLEBMC Public Health2025

    Incorporating SARS-CoV-2 surveillance into routine antenatal care is feasible and potentially sustainable when existing health system infrastructure, human resources, and surveillance systems are leveraged. Yet, careful planning is needed to anticipate implementation challenges and ensure high-quality data collection

  • Trends in Sars-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia

    Open AccessElizabeth Heilmann, Tannia Tembo et al.ARTICLEPLOS Global Public Health2024

    SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess exposure trends over time in Zambia. We conducted repeated cross-sectional SARS-CoV-2 seroprevalence surveys among pregnant women aged 15–49 years attending their first ANC visits in four districts of Zambia (two urban and two rural) during September 2021-S…

  • Geospatial patterns of progress towards Unaids ‘95-95-95’ targets and community vulnerability in Zambia

    Open AccessDiego F Cuadros, Tuhin Chowdhury et al.ARTICLEBMJ Global Health2023

    INTRODUCTION: In sub-Saharan Africa, HIV/AIDS remains a leading cause of death. The UNAIDS established the '95-95-95' targets to improve HIV care continuum outcomes. Using geospatial data from the Zambia Population-based HIV Impact Assessment (ZAMPHIA), this study aims to investigate geospatial patterns in the '95-95-95' indicators and individual-level determinants that impede HIV care continuum in vulnerable communities, providing insights into …

  • Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia

    Open AccessMpande Mukumbwa-Mwenechanya, Muhau Mubiana et al.ARTICLEPLOS Global Public Health2023

    Most people living with HIV (PLHIV) established on treatment in Zambia receive multi-month prescribing and dispensing (MMSD) antiretroviral therapy (ART) and are enrolled in less-intensive differentiated service delivery (DSD) models such as Fast Track (FT), where clients collect ART every 3–6 months and make clinical visits every 6 months. In 2019, Zambia introduced Isoniazid Preventive Therapy (IPT) with scheduled visits at 2 weeks and 1, 3, an…

  • HIV, syphilis, and hepatitis B virus infection and male circumcision in five Sub-Saharan African countries

    Open AccessMegan E Peck, Megan Bronson et al.ARTICLEPLOS Global Public Health2023

    Voluntary medical male circumcision (VMMC) has primarily been promoted for HIV prevention. Evidence also supports that male circumcision offers protection against other sexually transmitted infections. This analysis assessed the effect of circumcision on syphilis, hepatitis B virus (HBV) infection and HIV. Data from the 2015 to 2019 Population-based HIV Impact Assessments (PHIAs) surveys from Rwanda, Tanzania, Uganda, Zambia, and Zimbabwe were us…

  • Maintaining HIV testing and treatment services in Zambia during Covid-19

    Open AccessTina Chisenga, Menard Chihana et al.ARTICLEGlobal Health Action2023

    BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by a virus called severe acute respiratory syndrome coronavirus. As countries struggled to control the spread of the virus through among other measures closure of health facilities, repurposing of health care workers, and restrictions on people's movement, HIV service delivery was affected. OBJECTIVES: To assess the impact of COVID-19 on HIV service delivery in Zambia by comparing uptake o…

  • Intersection of alcohol use, HIV infection, and the HIV care continuum in Zambia

    Michael J Vinikoor, Izukanji Sikazwe et al.ARTICLEAIDS Care2023

    Through a nationally-representative household survey, we measured the prevalence and correlates of unhealthy alcohol use (UAU) in Zambia and its association with the HIV care continuum. Adolescent and adult (ages 15–59 years) data, including the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), from the 2016 Zambia Population-based HIV Impact Assessment, were analyzed. UAU was defined as AUDIT-C of 3 + points for women and 4 + for …

  • The early-stage comprehensive costs of routine PrEP implementation and scale-up in Zambia

    Open AccessCheryl Hendrickson, Lawrence Long et al.ARTICLEPLOS Global Public Health2022

    Pre-exposure prophylaxis (PrEP) is an effective HIV prevention option, but cost-effectiveness is sensitive to implementation and program costs. Studies indicate that, in addition to direct delivery cost, PrEP provision requires substantial demand creation and client support to encourage PrEP initiation and persistence. We estimated the cost of providing PrEP in Zambia through different PrEP delivery models. Taking a guidelines-based approach for …

  • Prevalence of and factors associated with late diagnosis of HIV in Malawi, Zambia, and Zimbabwe

    Open AccessAndreas D Haas, Elizabeth Radin et al.ARTICLEPLOS Global Public Health2022

    Introduction Late diagnosis of HIV (LD) increases the risk of morbidity, mortality, and HIV transmission. We used nationally representative data from population-based HIV impact assessment (PHIA) surveys in Malawi, Zambia, and Zimbabwe (2015–2016) to characterize adults at risk of LD and to examine associations between LD and presumed HIV transmission to cohabiting sexual partners. Methods We estimated the prevalence of LD, defined as CD4 count R…

  • A national HIV clinical mentorship program

    Open AccessMary Adetinuke Boyd, Sombo Fwoloshi et al.ARTICLEPLOS Global Public Health2022

    Although Zambia has increased the proportion of people living with HIV (PLHIV) who are on antiretroviral therapy (ART) in recent years, progress toward HIV epidemic control remains inconsistent. Some districts are still failing to meet the UNAIDS 90/90/90 targets where 90% of PLHIV should know their status, 90% of those diagnosed should be on ART, and 90% of those on ART should achieve viral load suppression (VLS) by 2020. Providing consistently …

  • Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia

    D Krebs, D W Krebs et al.ARTICLEAIDS Care2008

    Timely adherence to clinical and pharmacy appointments is well correlated with favourable patient outcomes among HIV-infected individuals on antiretroviral therapy. To date, however, there is little work exploring reasons behind missed visits or evaluating programmatic strategies to recall patients. For this study we implemented community-based follow-up of late patients as part of a large-scale programme for HIV care and treatment in Lusaka, Zam…